Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27381-27390 Newer>

The Motley Fool November 21, 2007 Jason Ramage	Dueling Fools: Nuance Bear Rebuttal The bears argue that Nuance Communications is on top, but only for now, as competition grows from many other sources.
The Motley Fool November 21, 2007 Rich Smith	This Ain't Your Mama's Humvee The biggest names in armored warfare are gearing up to vie for the Pentagon's Joint Light Tactical Vehicle program, which could be worth between $10 billion to $70 billion to the winner.
The Motley Fool November 21, 2007 Rich Smith	Medtronic Motors Ahead Shares of the medical equipment maker soared yesterday and continue to buck the downtrend on Wall Street, in the wake of a fiscal Q2 2008 earnings report that exceeded expectations for both sales and profits.
The Motley Fool November 21, 2007 Anders Bylund	Mr. Market Turns Sour on Sweet Gymboree Despite earnings above and beyond recently upped guidance, and raised full-year guidance once again, the children's clothing retailer's shares fall.
The Motley Fool November 21, 2007 Michael Leibert	UPS Hangs Tough UPS may be less vulnerable to an economic slowdown than its peer FedEx.
The Motley Fool November 21, 2007 Brian Lawler	Elan and Biogen Denied Elan's multiple sclerosis treatment is denied a label expansion in Europe. Investors, take note.
The Motley Fool November 21, 2007 Brian Lawler	Pfizer Finds an Old Friend Pfizer announces its purchase of partner Coley Pharmaceutical, securing Coley's novel technology for targeting toll-like receptors.
The Motley Fool November 21, 2007 Brian Orelli	Depression Hits Biovail An FDA decision on Biovail's depression drug could be another six months away.
The Motley Fool November 21, 2007 Alyce Lomax	Whole Foods' Whole Nine Yards Although Whole Foods Market missed analysts' earnings expectations for the quarter, it did beat with its revenue.
The Motley Fool November 21, 2007 Anders Bylund	HP Is Worth More Hewlett-Packard continues its bulldogish commitment to buying back its own stock, authorizing another $8 billion to do so.
<Older 27381-27390 Newer> Return to current articles.